RevBio® announced today that TETRANITE, the company's first of its kind regenerative "bone glue" has been approved for a 20-patient pilot study to measure the biomaterial's safety and efficacy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback